Haipaitec

Haipaitec is a specialized biotechnology company headquartered in Beijing, China, dedicated to the advancement of exosome-based therapeutic delivery systems. The company utilizes its proprietary Exo-DDS platform to engineer extracellular vesicles for the targeted transport of diverse payloads, including proteins, small molecules, and nucleic acids. By harnessing the natural properties of exosomes, Haipaitec seeks to improve the safety and efficacy profiles of treatments for oncology and autoimmune disorders. Their research focuses on overcoming the limitations of synthetic delivery vehicles, such as immunogenicity and poor tissue penetration. The company is currently progressing through the preclinical stages with a focus on establishing a robust pipeline of targeted therapies.